United States · FDA National Drug Code directory
Tirosint SOL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71858-0155_4e04737b-8d88-7c75-e063-6394a90a34c0
- Product NDC
- 71858-0155
- Form
- SOLUTION
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- IBSA Pharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190301
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 175 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (71858-0155-2) / 5 AMPULE in 1 POUCH (71858-0155-4) / 1 mL in 1 AMPULE (71858-0155-6) · 71858-0155-2
- 6 POUCH in 1 CARTON (71858-0155-5) / 5 AMPULE in 1 POUCH (71858-0155-4) / 1 mL in 1 AMPULE (71858-0155-6) · 71858-0155-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →